Clinical Trial Update: Single Dose Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Pevifoscorvir Sodium (ALG-000184) in Participants With Renal Impairment and in Healthy Participants With Normal Renal Function [Phase 1]

View source ↗

Summary

Phase 1 single-dose pharmacokinetics, safety and tolerability study of Pevifoscorvir Sodium (ALG-000184) in participants with renal impairment and in healthy pa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Pevifoscorvir Sodium (Pevifoscorvir sodium)

Snippet

Sponsor: Aligos Therapeutics | Conditions: Chronic Hepatitis B Infection | Phase 1 | Status: RECRUITING